Skip to main content

Table 4 SCIg infusion efficiency of the vial and PFS, cohorts, stratified by SCIg administration method (pump and manual push)

From: Subcutaneous immunoglobulin replacement therapy in patients with immunodeficiencies – impact of drug packaging and administration method on patient reported outcomes

Infusion characteristics

Vial cohort (A)

PFS cohort (B)

p values

Summary

n

Summary

n

A vs. B

All respondents

Infusion preparation time (mins) (median [IQR])

15 [10, 30]

64

15 [10, 20]

110

0.02*

Length of infusion (mins) (median [IQR])

70 [48, 90]

64

60 [35, 90]

110

0.07

Post-infusion clean up time (mins) (median [IQR])

5 [5, 10]

60

5 [5, 10]

108

0.89

Number of infusion sites, n (%)

1

2 (3.3%)

61

6 (5.7%)

106

0.12

2 or 3

41 (67.2%)

83 (78.3%)

≥4

18 (29.5%)

17 (16.0%)

Pump subgroup

Infusion preparation time (mins) (median [IQR])

20 [15, 30]

37

15 [10, 20]

37

0.20

Length of infusion (mins) (median [IQR])

75 [60, 90]

37

90 [60, 105]

37

0.33

Post-infusion clean up time (mins) (median [IQR])

6 [5, 10]

34

9 [5, 15]

36

0.54

Number of infusion sites, n (%)

1

0 (0.0%)

36

2 (5.6%)

36

0.15

2 or 3

21 (58.3%)

25 (69.4%)

≥4

15 (41.7%)

9 (25.0%)

Manual push subgroup

Infusion preparation time (mins) (median [IQR])

15 [10, 20]

27

10 [8, 15]

73

0.23

Length of infusion (mins) (median [IQR])

60 [40, 90]

27

50 [30, 75]

73

0.06

Post-infusion clean up time (mins) (median [IQR])

5 [2, 5]

26

5 [3, 10]

72

0.46

Number of infusion sites, n (%)

1

2 (8.0%)

25

4 (5.7%)

70

0.92

2 or 3

20 (80.0%)

58 (82.9%)

≥4

3 (12.0%)

8 (11.4%)

  1. Data were compared using the Mann-Whitney test due to the non-normality (skewness) of the distributions. Significant p-values are highlighted in bold
  2. *Although the median infusion preparation times are numerically similar for the vial and PFS cohorts, the difference between the two distributions is significant and is demonstrated by the mean (± standard deviation) values of 19.2 (± 12.4) mins and 16.7 (± 15.6) mins, respectively. IQR interquartile range, mins minutes, PFS pre-filled syringes, SCIg subcutaneous immunoglobulin